for Oct 08, 2019 through Oct 14, 2019
JUST RELEASED 🔥🔥🔥
— Antibiotic Steward (@ABsteward) October 9, 2019
Top New ID/Stewardship Journal Articles Link-O-Rama: October 2019https://t.co/QPmYPFPtHu
A monthly post by @IDstewardship & @ABsteward #IDTwitter #IDMedEd #IDJClub #medtwitter #MedEd #FOAMed
If you find this helpful Please RT/❤️share w others pic.twitter.com/4z8NuqmNG1
NEW🔥 in OFID Dr. Kollef et Al @ScottMicek
— Antibiotic Steward (@ABsteward) October 9, 2019
Pathogen-Negative Sepsis—An Opportunity for Antimicrobial Stewardship. #IDTwitter https://t.co/JwGYErFbEw pic.twitter.com/3giNFXNnKB
DANCE Trial Published 🔥🔥
— Antibiotic Steward (@ABsteward) October 13, 2019
NEW @CMIJournal
Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomised, double-blind, placebo-controlled, non-inferiority trial. #IDTwitter https://t.co/WiTJbKs5pn pic.twitter.com/rsY52ae50y
5 days penicillin V (4 x daily) seems to be just as effective as 10 days (3x daily) for group A streptococcal throat infection. Time to cut down duration? @AntibioticLeeds https://t.co/vnpV7rhnNH
— Jonathan Sandoe (@j_sandoe) October 10, 2019
Safe to use a direct oral challenge to confirm current tolerance with a benign penicillin-associated rash more than 1 year ago. Multicenter Australian Study to Determine Criteria for Low- and High-Risk Penicillin Testing in Outpatients. - PubMed - NCBI https://t.co/ZOdZqnYFuH
— Eric Macy (@EricMacyMD) October 12, 2019
‘There is increasing evidence psycho-social factors can influence antimicrobial prescribing practice in hospitals & the community, & represent potential barriers to antimicrobial stewardship interventions’ #JACNews https://t.co/gPL2YyTiXF
— BSAC (@BSACandJAC) October 8, 2019
Are you interested in Antimicrobial Stewardship? We are looking for two enthusiastic pharmacists to work within primary or secondary care, with lots of opportunities for cross-sector working. Closing soon - 10th of October https://t.co/lleIABxZ9C @UhbBay @RogerWill64 @jvin715
— Julie Harris (@julieharris1980) October 8, 2019
NEW🔥 in AAC @ASMicrobiology @a_lepak
— Antibiotic Steward (@ABsteward) October 8, 2019
Cefepime/Zidebactam Pharmacodynamic Target Analysis against MBL producing Enterobacteriaceae in the Neutropenic Mouse Pneumonia Model. #IDTwitter https://t.co/kBn7819sdZ
New in OFID: At one center, patients with sepsis who tested negative for pathogens received antibiotics for several days anyway, suggesting a target for antimicrobial stewardship efforts. https://t.co/fDqL8yDmxg #OpenForumInfectDis #IDSAJournals #DISARMSuperbugs @PaulSaxMD
— IDSA (@IDSAInfo) October 12, 2019
Our latest publication in @JAMMI_Journal: a pilot study of a province-wide #antibiotic use tracking and reporting system#VisualAbstract https://t.co/4YKZisityB pic.twitter.com/8GUCFxTIqH
— Brad Langford (@BRxAD) October 12, 2019
‘Managing urinary tract infections’. An article I wrote, published in @med_indonews. An overview of the management approached to UTI’s, highlighting the importance of antimicrobial stewardship. @PriscillaLynch @itcarlow @The_ISHA @PracticeNurses https://t.co/elp8qVCdgN pic.twitter.com/9hOcg5S8Xc
— Theresa Lowry-Lehnen (@lehnent) October 11, 2019
“I vaccinate because I want no part in making infectious diseases great again,” writes @lymanbiopharma in this excellent @sciam article dissecting the anti-vaccine movement. #VaccinesWork & protect against diseases that used to routinely kill millions. https://t.co/Lx0hFrcF9t
— Seth Berkley (@GaviSeth) October 8, 2019
A NEW 🔥 case report @pbsouk @PharmacoJournal recommends a dose of CAZ‐AVI 2.5 g infused over 2 hours every 8 hours for critically ill patients who are being treated for PSA pneumonia and are receiving CVVHDF. #IDTwitter https://t.co/Qtm6RCV4Y3 pic.twitter.com/JXkTWp4pjc
— Antibiotic Steward (@ABsteward) October 9, 2019
Don't forget to register to the 3rd Texas Medical Conference on Antimicrobial resistance and Stewardship, Houston, TX, January 22-24, 2020. Abstract deadline, December 6, 2019. Details at https://t.co/hbJc3II3d7 Tackling AMR is a mission for all of us!
— Cesar Arias (@SuperBugDoc) October 8, 2019
NEW🔥 in OFID @BradCutrellMD#WhyID: Crowdsourcing the Top Reasons to Choose Infectious Diseases in the Age of Twitter. #IDTwitter #medtwitter https://t.co/h7tAIHp3ys pic.twitter.com/2hMbSi2oXL
— Antibiotic Steward (@ABsteward) October 9, 2019
📢BREAKING NEWS📢
— TARGETantibiotics (@TARGETabx) October 10, 2019
The new #TARGET website is up and running as of...NOW❗❕
💻📲
Head over to https://t.co/7OnZZuC94F to check out the new and improved look and feel and tweet us your feedback #TARGETtoolkit #RCGP #antimicrobialstewardship #primarycare pic.twitter.com/K4WJYPfYim
MacConkey agar is one of the most recognizable media in the microbiology laboratory. In a new Bugs & Drugs article, we discuss the history of this ubiquitous medium and how the formulation changed over its 120 year history. https://t.co/hqkXneXZLr #ASMClinMicro
— ASM (@ASMicrobiology) October 14, 2019
Vaginal microbiome transplantation (VMT) in women with intractable bacterial vaginosis | @NatureMedicine Interesting study, 4/5 patients with intractable BT improved with VMT.Thoughts? @DrJeanneM @colleenkraftmd @DrJenGunter https://t.co/xYzyLlwoRW
— Carlos del Rio (@CarlosdelRio7) October 9, 2019
Emotional, cognitive and social factors of antimicrobial prescribing: can antimicrobial stewardship intervention be effective without addressing psycho-social factors? https://t.co/TqTb49Apx4
— gabriel birgand (@GBirgand) October 9, 2019
Why should med residents pursue a career in ID? A new OFID commentary lays out the top 10 reasons the field is exciting, satisfying, & important, crowdsourced from #IDTwitter: https://t.co/mNAYZN2bz8 #OpenForumInfectDis #IDSAJournals #WhyID #FutureofID @BradCutrellMD @PaulSaxMD
— IDSA (@IDSAInfo) October 10, 2019
#WhyID! This fun read in OFID is just the thing for your Friday reading as you prepare for your weekend -- a David Letterman-style "Top 10 Reasons" to choose ID. Which one of the 10 is your favorite? Any @BradCutrellMD might have missed? https://t.co/5mQiNX4pLq
— Paul Sax (@PaulSaxMD) October 11, 2019
📄 New article!!!@krutu8 and I 🎙 interview @ABOsteward about his experiences and stewardship in 🇹🇭 Thailandhttps://t.co/gZ11dnFrRL pic.twitter.com/8bf8BoKrcs
— Bug Pharmacist 💊🦠 Tim Gauthier (@IDstewardship) October 9, 2019
💥October in NYC and #ACCPAM19! Don't miss this co-sponsored session by @accpinfdprn and @SIDPharm. Power Gaps in Stewardship with @BossoJr, @n_mercuro, Stephanie Harding, and @whitajones. Full program here: https://t.co/2Vl8XywLq0 #IDPRN pic.twitter.com/2pJrV5rF5W
— SIDP (@SIDPharm) October 9, 2019
NEW🔥 retrospective 🇹🇼 study in IJAA
— Antibiotic Steward (@ABsteward) October 14, 2019
Suggest that anidulafungin single therapy may be an effective and alternative treatment for PCP in patients who cannot tolerate TMP-SMZ. #IDTwitter @ischemo
https://t.co/dPY4JUAkCY
Opportunities for #antimicrobialstewardship in COPD: Patients with severe COPD have the highest rates of antibiotic use but the majority of antibiotics are prescribed for those with mild to moderate disease. https://t.co/M3l8semVYH via @BSACandJAC
— Brad Langford (@BRxAD) October 14, 2019
Full paper published here:
— Paul Sax (@PaulSaxMD) October 13, 2019
Changes in Body Mass Index and Atherosclerotic Disease Risk Score After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide https://t.co/f25zrydCo3 https://t.co/Vn3rGFFpMs
NEW 🔥in CID @dr_michaelmarks@gpollara
— Antibiotic Steward (@ABsteward) October 11, 2019
Clinical and economic impact of implementing OVIVA criteria on patients with bone and joint infections in OPAT. #IDTwitter #medtwitter #OVIVA https://t.co/oqNI1fLhfT pic.twitter.com/tNHi9qY8Gt
Wow! Sell out event with over 120 attendees registered to attend @UKCPAPIN Masterclass _Taking stewardship to the next level on Friday 11th October in Birmingham. See you all in birmingham. @UKCPA@DrDianeAshiru @AntibioticLeeds @RakheePatel81 https://t.co/uDQm3P272S
— Tejal Vaghela (@tejalvaghela15) October 9, 2019
Make ART. With #BACTERIA. @CountrCultrLabs is hosting their final public #AgarArt workshop this Sat, 10/12 11 am in #Oakland: https://t.co/Me9AXnEIg0. Your #microbialmasterpiece could win $200 in prizes from ASM's Agar Art 2019 Contest! #DIYbio #SciArt #BioArt #BayArea #Oaktown
— ASM (@ASMicrobiology) October 14, 2019
Researchers are using machine learning approaches to more quickly detect #antibioticresistance in bacteria. Read the full study from @NatureNews: https://t.co/DkVXpj0WW0
— Save Antibiotics (@saveantibiotics) October 12, 2019
NEW🔥 in AAC @ASMicrobiology association of acute kidney injury with the concomitant use of vancomycin and piperacillin/tazobactam in children: A systematic review and meta-analysis. #IDTwitter https://t.co/gPSYJpwQSD
— Antibiotic Steward (@ABsteward) October 8, 2019
Implementation of a rapid respiratory multiplex assay reveals opportunities for antimicrobial stewardship and clinical practice @JClinMicro https://t.co/3sHZVL4CtJ #ASMClinMicro pic.twitter.com/xcOP9aUO26
— ASM (@ASMicrobiology) October 9, 2019
-We know TDF lowers lipids. A study in HIV negative people proved this.
— Paul Sax (@PaulSaxMD) October 8, 2019
- The iPrEx placebo arm suggests TDF lowers weight (wt lower in TDF vs placebo).
-Does TAF increase lipids and weight, or is this the lack of TDF effect?
-Great graphic!https://t.co/NdRGWsS6UI https://t.co/Ngiw0Vw39K
NEW reflections post: cluster RCT on whether to use single rooms to apply contact precautions for ESBL-E carriers; a fairly comprehensive no for E. coli; not sure sure about for Klebsiella https://t.co/m3Nr2XfYQm @TheLancetInfDis Congrats @MarcBonten @avipnl @jankluytmans et al.
— Jon Otter (@jonotter) October 11, 2019
Rotavirus infection may turn on type 1 diabetes.
— Microbes&Infection (@MicrobesInfect) October 10, 2019
Following the recent introduction of #rotavirus vaccination, there has been a 15% decrease in the incidence of type 1 #diabetes in Australian children.https://t.co/PdwCLoZ8VW pic.twitter.com/edOuaG0OEC
Children are offered the measles, mumps & rubella (MMR) vaccine between 12 and 13 months & again at around 3 years and 4 months. Measles is one of the most infectious diseases known. Protect your child and get the MMR vaccine when it’s due. Get the facts https://t.co/nfrKEc252N pic.twitter.com/CfmJoA6jPD
— Immunise Scotland (@NHSImmuniseScot) October 10, 2019
CRISPR enzyme programmed to kill viruses in human cells.
— Microbes&Infection (@MicrobesInfect) October 10, 2019
Researchers previously adapted #Cas13 as a tool to cut & edit human RNA. This study is one of the first to harness Cas13, or any #CRISPR system, as an #antiviral in cultured human cells.https://t.co/3ozjtPyWfq #virus pic.twitter.com/DuJB2qS6hV
A goal of #antibiotic stewardship is to use the best drugs for a condition, which helps minimize the consequences of unnecessary use, @pewhealth’s David Hyun, M.D. said. https://t.co/QWf3Wk7R6t @FierceHealth
— Save Antibiotics (@saveantibiotics) October 14, 2019
Antimicrobial resistance (AMR) in chickens & pigs has ~ trebled in developing countries since 2000, experts warn.#AMR is rapidly rising among farm animals in low- & middle-income countries such as China, India & Brazil.https://t.co/a7DyR8f92Z #antibioticresistance pic.twitter.com/hPjpgJLCr6
— Microbes&Infection (@MicrobesInfect) October 12, 2019
DYK: Most new #antibiotics aren't based on new ways to kill bacteria. They’re actually incremental improvements on existing drugs where resistance is already developing, @bioharmonytrx and @UCSDnews’s David Pride write. https://t.co/iSbIrAPuJd
— Save Antibiotics (@saveantibiotics) October 11, 2019
Join us at the next NCAS seminar on Wed, 16 Oct: A/Prof. Mark Davis from Monash University will speak on the topic - 'Digital media and general public antimicrobial stewardship'. A/Prof. Davis is researching media and policy around AMR - https://t.co/YxNNVnVfpB pic.twitter.com/klCV1YJfCP
— NCAS_Australia (@NCAS_Aus) October 9, 2019
New test diagnoses #LymeDisease within 15 minutes.
— Microbes&Infection (@MicrobesInfect) October 12, 2019
Biomedical engineers have developed a rapid microfluidic test that can detect #Lyme disease with similar performance as the standard 2-tiered approach in a much shorter time.https://t.co/mclvOYFk55 #Borrelia pic.twitter.com/R1nZolBZpm
NEW🔥 in CID @PaulSaxMD @drmoupali @kerlands
— Antibiotic Steward (@ABsteward) October 14, 2019
Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials. #IDTwitter #medtwitter https://t.co/kQUSRTJYgc pic.twitter.com/12BMktr6bB
A Virus in Koala #DNA Shows #evolution in Action.
— Microbes&Infection (@MicrobesInfect) October 11, 2019
Many animals, including humans, have DNA left over from ancient viral infections. In koalas, researchers are studying the process in real time.https://t.co/nhLO2nraNH #retrovirus #KoRV pic.twitter.com/65HBd09y9Y
Register for CIDRAP's live webcast on the Value of Diagnostics in Antimicrobial Stewardship: An Asia-Pacific Outlook! Nov 5th, 2:00 PM (GMT+8:00). Register below 👇 @CIDRAP_ASP https://t.co/u6G06vEPR9 pic.twitter.com/sw60tSUIKx
— CDDEP (@CDDEP) October 11, 2019
Despite poor compensation, long hours, there are lots of reasons that ID docs love what they do. Here are 10 reasons #WhyID: Crowdsourcing the Top Reasons to Choose Infectious Diseases in the Age of Twitter https://t.co/m9mRnd2bXO
— Andrew Pavia (@AndrewPaviaMD) October 13, 2019
Ahead of Print - Nasopharyngeal Pneumococcal Density during Asymptomatic Respiratory Virus Infection and Risk for Subsequent Acute Respiratory Illness - Volume 25, Number 11—November 2019 - Emerging Infectious Diseases journal - CDC https://t.co/xelvlS2M5D via @CDCgov
— Jorge E. Vidal (@JorgeEVidal1) October 12, 2019
Fact: Bacteria are becoming increasingly resistant to existing #antibiotics, but the drugs aren’t profitable enough to keep major pharmaceutical companies invested in developing novel replacements. https://t.co/wB4pzw59q6
— Save Antibiotics (@saveantibiotics) October 10, 2019
The @GlobalFund replenishment means over 110 affected countries will receive critical financial support to scale up infectious diseases responses and #StepUpTheFight against drug resistance and other threats. https://t.co/L4XLM4i3kl pic.twitter.com/IiBqyBj5k6
— World Health Organization (WHO) (@WHO) October 10, 2019
"I really wanted to call attention to the recent #polio and #measlesoutbreaks in the Philippines." IDSA member Dr. Edsel Salvana (@EdselSalvana) on why he chose to dress as “plague doctor” at #IDWeek2019. https://t.co/kNPba8e3vF#WhyIVaccinate #VaccinesWork @IDWeek2019
— IDSA (@IDSAInfo) October 9, 2019
Just published 🔥 @CMIJournal@danlivorsi @MGoto_Iowa @eliowa@balexander51 @IC_CADRE
— Antibiotic Steward (@ABsteward) October 8, 2019
Post-discharge oral antimicrobial use among hospitalized patients across an integrated national healthcare network. #IDTwitter #medtwitter https://t.co/Mh8JA8YRK4 pic.twitter.com/VvZBIapvwJ
Created by Cameron Forbes. Last updated October 15, 2019 at 05:13 EST.